Frank Witney
Former Chief Executive Officer, Affymetrix, Inc.
Dr. Witney most recently served as President and Chief Executive Officer of Affymetrix, Inc. (now part of Thermo Fisher Scientific), which specialized in microarray technology and cellular analysis. Previously, Dr. Witney was President and Chief Executive Officer of Dionex Corp., a market leading ion and high performance liquid chromatography company. Prior to that, Dr. Witney first joined Affymetrix when it acquired Panomics Inc., a quantitative biology company, which he led as President and Chief Executive Officer. He previously held the role of President of PerkinElmer’s Drug Discovery Tools division following the acquisition of Packard BioScience in 2001, where he served as President and Chief Operating Officer. Dr. Witney also held several positions at Bio-Rad Laboratories, leading that company's efforts to enter the proteomic and bioassay technologies market.
Dr. Witney was a post-doctoral fellow at the National Institutes of Health from 1980 to 1983 and holds a doctorate in molecular and cell biology from Indiana University. He earned an undergraduate degree in microbiology from the University of Illinois. Dr. Witney is currently Chairman of the Board for Gyros Protein Technologies AB and also holds Board positions for Cerus Corporation and Genoptix.
Dr. Witney brings deep market knowledge and over 30 years of leadership experience across the life sciences, diagnostics and analytical instruments industry.